Page last updated: 2024-09-03

1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin and Lung Neoplasms

1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin has been researched along with Lung Neoplasms in 1 studies

*Lung Neoplasms: Tumors or cancer of the LUNG. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerny, EA; Maccoss, M; Patel, KR; Rahman, YE1

Other Studies

1 other study(ies) available for 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin and Lung Neoplasms

ArticleYear
The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:8

    Topics: Animals; Antineoplastic Agents; Cytarabine; Delayed-Action Preparations; Female; Injections, Intraperitoneal; Injections, Intravenous; Liposomes; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tissue Distribution

1984